A case of CD30+ nasal natural killer/T-cell lymphoma

American Journal of Dermatopathology

Volumn 30, Issue 6, 2008, Pages 567-571

  Ferenczi, Katalin ^a   Summers, Pamela ^a   Aubert, Pamela ^b   Cooper, Brenda ^a   Meyerson, Howard ^a   Cooper, Kevin D ^a   Honda, Kord ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD30; Cutaneous lymphoma; NK lymphoma

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE; MEPREDNISONE; PENTOSTATIN; PREDNISONE; T LYMPHOCYTE RECEPTOR; VALACICLOVIR; VINCRISTINE SULFATE;

ADULT; ANAMNESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LABORATORY TEST; MULTIPLE CYCLE TREATMENT; NK T CELL LYMPHOMA; NOSE CONGESTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY; VIRUS INFECTION; CUTANEOUS T CELL LYMPHOMA; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; METABOLISM; NATURAL KILLER T CELL; NOSE TUMOR; PATHOLOGY; SKIN TUMOR;

ADULT; ANTIGENS, CD30; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMA, T-CELL, CUTANEOUS; NATURAL KILLER T-CELLS; NOSE NEOPLASMS; SKIN NEOPLASMS;

EID: 59849129604     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318184bc3f     Document Type: Article

References (21)

1. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia. 2005;19:2186-2194.
2. Willemze R, Meijer CJ. Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC. J Cutan Pathol. 2006;(Suppl 1):18-26.
3. Aviles A, Diaz NR, Neri N, et al. Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients. Clin Lab Haematol. 2000;22:215-220.
4. Nakamura S, Kato M, Ichimura K, et al. Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese. Pathol Int. 1997;47:38-53.
5. Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer. 2003;97:610-627.
6. Mraz-Gernhard S, Natkunam Y, Hoppe RT, et al. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol. 2001;19:2179-2188.
7. Bekkenk MW, Jansen PM, Meijer CJ, et al. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol. 2004;15:1097-1108.
8. Gaal K, Sun NC, Hernandez AM, Arber DA, et al. Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol. 2000;24:1511-1517.
9. Al-Hakeem DA, Fedele S, Carlos R, et al. Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol. 2007;43:4-14.
10. Kinney MC, Jones D. Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types. Am J Clin Pathol. 2007;127:670-686.
11. Hasserjian RP, Harris NL. NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype. Am J Clin Pathol. 2007;127:860-868.
12. Querfeld C, Kuzel TM, Guitart J, et al. Primary cutaneous CD30+ lymphoproliferative disorders: new insights into biology and therapy. Oncology (Williston Park). 2007;21:689-696; discussion 699-700.
13. Kim YC, Yang WI, Lee MG, et al. Epstein-Barr virus in CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea. Int J Dermatol. 2006;45:1312-1316.
14. de Bruin PC, Kummer JA, van der Valk P. Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization. Blood. 1994;84:3785-3791.
15. Krenacs L, Wellmann A, Sorbara L. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood. 1997;89: 980-989.
16. Oudejans JJ, Kummer JA, Jiwa M, et al. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol. 1996;148:233-240.
17. Liu W, Lacouture ME, Jiang J, et al. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma. J Cutan Pathol. 2006;(Suppl 2):46-51.
18. Venizelos I, Tamiolakis D, Lambropoulou M, et al. An unusual case of posttransplant peritoneal primary effusion lymphoma with T-cell phenotype in a HIV-negative female, not associated with HHV-8. Pathol Oncol Res. 2005;11:178-181.
19. Servitje O, Gallardo F, Estrach T, et al. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol. 2002;147:1147-1158.
20. Barberio E, Thomas L, Skowron F, et al. Transformed mycosis fungoides: clinicopathological features and outcome. Br J Dermatol. 2007;157: 284-289.
21. Li T, Zhang B, Ye Y, et al. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas. Hum Pathol. 2006;37: 54-60.